Keywords
Cannabis toxicity
Cortex
Memory
Hippocampus
How to Cite
Abstract
Summary: The most abused illicit drug in both the developing and the developed world is Cannabis disposing users to varying forms of personality disorders. However, the effects of cannabis on cortico-hippocampal architecture and cognitive behaviours still remain elusive. The present study investigated the neuro-cognitive implications of oral cannabis use in rats. Eighteen adult Wistar rats were randomly grouped to three. Saline was administered to the control rats, cannabis (20 mg/kg) to the experimental group I, while Scopolamine (1 mg/kg. ip) was administered to the last group as a standard measure for the cannabis induced cognitive impairment. All treatments lasted for seven consecutive days. Open Field Test (OFT) was used to assess locomotor activities, Elevated Plus Maze (EPM) for anxiety-like behaviour, and Y maze paradigm for spatial memory and data subjected to ANOVA and T test respectively. Thereafter, rats were sacrificed and brains removed for histopathological studies. Cannabis significantly reduced rearing frequencies in the OFT and EPM, and increased freezing period in the OFT. It also reduced percentage alternation similar to scopolamine in the Y maze, and these effects were coupled with alterations in the cortico-hippocampal neuronal architectures. These results point to the detrimental impacts of cannabis on cortico-hippocampal neuronal architecture and morphology, and consequently cognitive deficits.
References
Ashley M., Schnakenberg M., Kelsey A.B., Beshaun J.D., Elizabeth A.S., Kelly S., Paul H.L. (2016). Compared to High and Low Cannabis Use, Moderate Use is Associated with Fewer Cognitive Deficits in Psychosis, Schizophrenia Research: Cognition. doi:10.1016/j.scog.2016.09.001
Bahareh A., Sasan A., Golnaz V., Azadeh M. (2016) Learning and Memory Performance After Withdrawal of Abused Agents: A Review Study. Iran J Psychiatry Behav Sci. doi:10.17795/ijpbs-1822
Batalla A., Bhattacharyya S., Yücel M., Fusar-Poli P., Crippa J.A., Nogué S., Torrens M., Pujol J., Farré M., Martin-Santos R. (2013). Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings. PLosOne, 8
Batalla A., Crippa J.A., Busatto G.F., et al. (2014). Neuroimaging studies of acute effects of THC and CBD in humans and animals: a systematic review. Curr Pharm Des. 20(13):2168-2185.
Battistella G., Fornari E., Annoni J.M., Chtioui H., Dao K., Fabritius M., Favrat B., Mall J.F., Maeder P., Giroud C. (2014). Long-term effects of cannabis on brain structure. Neuropsychopharmacology. 39(9):2041–2048
Bianconi F., Bonomo M., Marconi A., Kolliakou A., Stilo S.A., Iyegbe C., Gurillo Muñoz P., Homayoun S., Mondelli V., Luzi S., Dazzan P., Prata D., La Cascia C., O’Connor J., David
Bloomfield M.A.P, Mouchlianitis E., Morgan C.J.A., Freeman T.P., Curran H.V., Roiser J.P., Howes O.D. (2016). Salience attribution and its relationship to cannabis-induced psychotic symptoms. Psychological Medicine. doi:10.1017/S0033291716002051
Christian N., Susana O., Elena H., Iris B., Ana B., Montserrat D., Bernardo S., Núria del C., GENIPE Group, Judith U. (2016). Cannabis use and cognitive function in first episode psychosis: differential effect of heavy use. Psychopharmacology. 233:809–821 DOI:10.1007/s00213-015-4160-2
Churchwell J.C., Kesner R.P. (2011). Hippocampal-prefrontal dynamics in spatial working memory: Interactions and indepen-dent parallel processing. Behav. Brain Res. 225,389–395.
David J.C. (2013). “Cannabis and psychosis: what causes what?”. F1000 Medicine Reports, 5:1. doi:10.3410/M5-1
Desirée B.S., Marieke E.V., Roshan C., Ellen R.A.D., Barbara F., Janelle H.P.V., Johannes G.R., Robbert J.V. (2016). Acute effects of cocaine and cannabis on reversal learning as a function of COMTand DRD2 genotype. Psychopharmacology (2016) 233:199–211. DOI 10.1007/s00213-015-4141-5 Desrosiers N., Ramaekers J.G., Chauchard E., Gorelick D.A., Huestis M.A. (2015). Smoked Cannabis’ Psychomotor and Neurocognitive Effects in Occasional and Frequent Smokers. Journal of Analytical Toxicology. 1–11. doi:10.1093/jat/bkv012
Downer E.J. and Campbell V.A. (2010). Phytocannabinoids, CNS cells and development: A dead issue? Drug Alcohol Rev, 29 : 91–8 .
Fontes M.A., Bolla K.I., Cunha P.J., Almeida P.P., Jungerman F., Laranjeira R.R., Bressan R.A., Lacerda A.L.T. (2011). Cannabis use before age 15 and subsequent executive functioning. British Journal of Psychiatry 198, 442–447.
Gage S.H., Hickman M., Zammit S. (2015) Association between cannabis and psychosis: epidemiologic evidence. Biol Psychiatry. doi:10.1016/j.biopsych.2015.08.001
Hall W. (2015). What has research over the past two decades revealed about the adverse health effects of recreational cannabis use? Addiction 110, 19–35.
Hester R., Nestor L., Garavan H. (2009). Impaired error awareness and anterior cingulate cortex hypoactivity in chronic cannabis users. Neuropsychopharmacology 34(11):2450–2458
Imam A., Ajao M.S., Ajibola M.I., Amin A., Abdulmajeed A.I., Lawal A.Z., et al. (2016a). Black seed oil reversed scopolamine-induced Alzheimer and cortico-hippocampal neural alterations in male Wistar rats. Bulletin–Faculty of Pharmacy, Cairo University.54:49–57 http://dx.doi.org/10.1016/j.bfopcu.2015.12.005.
Imam A., Ajao M.S., Amin A., Abdulmajeed W.I., Ibrahim A., Olajide O.J., Ajibola M.I., Alli-oluwafuyi A., Balogun W.G. (2016b). Cannabis induced moto-cognitive dysfunction in Wistar rats: ameliorative efficacy of Nigella Sativa. Malays J Med Sci. 23(5):17–28.
http://dx.doi.org/10.21315/mjms2016.23.5.3
Juknat A., Kozela E., Kaushansky N., Mechoulam R., Vogel Z. (2016). Anti-inflammatory effects of the cannabidiol derivative dimethylheptyl-cannabidiol– studies in BV-2 microglia and encephalitogenic T cells. DOI 10.1515/jbcpp-2015- 0071
Justine R., TaniaV., Marion R., Marie-Odile K., Zsolt L., Gwenaëlle L., Thérèse M.J. (2016). Chronic cannabinoid exposure during adolescence leads to long-term structural and functional changes in the prefrontal cortex. European Neuropsychopharmacology. 26, 55–64
Keeley RJ, et al. (2015) Part II: Strain- and sex-specific effects of adolescent exposure to THC on adult brain and behaviour: Variants of learning, anxiety and volumetric estimates. Behav Brain Res, http://dx.doi.org/10.1016/j.bbr.2015.01.001
Lynch M.E. (2016). Cannabinoids in the management of chronic pain: a front line clinical perspective. J Basic Clin Physiol Pharmacol. DOI: 10.1515/jbcpp-2015-0059
Miech R.A., Johnston L.D., O’Malley P.M., Bachman J.G., Schulenberg J.E. (2014). Monitoring the future. National survey results on drug use 1975–2014 (NIDA, 2014).
Myles H., Myles N., Large M. (2015). Cannabis use in first episode psychosis: meta-analysis of prevalence, and the time course of initiation and continued use. Aust N Z J Psychiatry.
doi:10.1177/0004867415599846
Odokuma E.I., OgborOmorie E. (2015) Histomorphologic effects of Cannabis sativa on the brains of adult Wistar rats. Ann Bioanthropol. 3:2932.
Okon V.E., Obembe A.O., Nna V.U., Osim E.E. (2014). Long-Term Administration of Cannabis sativa on Locomotor and Exploratory Behavior in Mice. Research in Neuroscience, 3(1): 7-21
Omar M.E.A., Eman R.Y., Nermeen S., (2014). Biochemical, Immunological, DNA and Histopathological Changes Caused by Cannabis Sativa in the Rat. Journal of Neurology and Epidemiology 2, 6-16
Omar M.E.A., Neveen A.S., Marwa E.S., Noha A.A., Jihan S.H., Zakaria A.E. (2013). Cannabis-Induced Impairment of Learning And Memory: Effect Of Different Nootropic Drugs. Excli Journal 12:193-214 Issn 1611-2156
Orr C., Morioka R., Behan B., et al. (2013). Altered resting-state connectivity in adolescent cannabis users. Am J Drug Alcohol Abuse. 39(6):372-381
Ramaekers J.G., van Wel J.H., Spronk D.B., Toennes S.W., Kuypers K.P.C., Theunissen E.L., Verkes R.J. (2016). Cannabis and tolerance: acute drug impairment as a function of cannabis use history. Scientific Reports. 6:26843. DOI: 10.1038/srep26843
Renard J., Krebs M., Pen G.L., Jay T.M., (2014). Long-term consequences of adolescent cannabinoid exposure in adult psychopathology. Front.Neurosci.8,1–14. Rosales–Corral S., Hernández L., Gallegos M. (2015). Cannabinoids in Neuroinflammation, Oxidative Stress and Neuro Excitotoxicity. Pharm Anal Acta 6:346. doi:10.4172/2153-2435.1000346
Schoeler T., Kambeitz J., Behlke I., Murray R., Bhattacharyya S. (2016). The effects of cannabis on memory function in users with and without a psychotic disorder: findings from a combined meta-analysis. Psychological Medicine. 46, 177–188. doi:10.1017/S0033291715001646
Schuster R.M., Crane N.A., Mermelstein R., Gonzalez R. (2015). Tobacco may mask poorer episodic memory among young adult cannabis users.
Neuropsychology 29(5):759–766
Smith A.M., Longo C.A., Fried P.A., Hogan M.J.,
Cameron I. (2010). Effects of marijuana on visuospatial working memory: an fMRI study in young adults. Psychopharmacology (Berl) 210(3):429–438
Solowij N., Walterfang M., Lubman D.I., Whittle S., Lorenzetti V., Styner M., Velakoulis D., Pantelis C., Yücel M. (2013). Alteration to hippocampal shape in cannabis users with and without schizophrenia. Schizophr Res 143(1):179–184
Subbaraman M.S. and Kerr W.C. (2015) Simultaneous versus concurrent use of alcohol and cannabis in the national alcohol survey. Alcohol Clin Exp Res 39(5):872–879
Tzadok M., Uliel-Siboni S., Linder I., Kramer U., Epstein O., Menascu S., Nissenkorn A., Yosef O.B., Hyman E., Granot D., Dor M., Lerman-Sargie T., Ben-Zeev B. (2016). CBD- enriched medical cannabis for intractable pediatic epilepsy: the curent Israeli experience. Seizure 35: 41-44.
Valerie C.H., Freeman T.P., Claire M., David A.L., Celia J.A.M., Loren H.P. (2016) Keep off the grass? Cannabis, cognition and addiction. Nature Reviews. Neuroscience. 2016. doi:10.1038/nrn.2016.28
Velasco G., Hernandez-Tiedra S., Davila D., Lorente M. (2016). The use of cannabinoids as anticancer agents. Progress Neuro-Psychopharmacol Biol Phychiatry 64: 259-266.
Wahab I.A., Habeeb B.S., Maymunah O.Z., Aminu I., Abdulbasit A., Sikiru A.B., Lukuman A.O., Bamidele V.O. (2016). Honey prevents neurobehavioural deficit and oxidative stress induced by lead acetate exposure in male wistar rats- a preliminary study. Metabolic Brain Diseases. 31:37–44. DOI 10.1007/s11011-015-9733-6
Yasmin L., Hurd M.M., Michael L., Miller D.J. (2014). Trajectory of adolescent cannabis use on addiction vulnerability. Neuropharmacology 76
Zalesky A., Solowij N., Yücel M., Lubman D.I., Takagi M., Harding I.H., Lorenzetti V., Wang R., Searle K., Pantelis C., Seal M. (2012). Effect of long-term cannabis use on axonal fibre connectivity. Brain. 135,2245–2255.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.